|
Jul 25
|
Stifel Keeps Buy Rating on Compass Therapeutics (CMPX)
|
|
Jul 22
|
Compass Therapeutics (CMPX) Gains Analyst Confidence with Promising Cancer Pipeline
|
|
Jul 15
|
Compass Therapeutics And 2 Other Promising Penny Stocks To Watch
|
|
Jun 12
|
Compass Therapeutics And 2 Other Promising Penny Stocks For Your Watchlist
|
|
May 28
|
Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference
|
|
Oct 4
|
Compass Therapeutics Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
|
|
Aug 22
|
Institutional investors own a significant stake of 50% in Compass Therapeutics, Inc. (NASDAQ:CMPX)
|
|
Nov 9
|
Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments
|
|
Nov 9
|
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
|
|
Nov 7
|
Compass Therapeutics to Participate in Upcoming Investor Events
|